Cargando…
PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability
An important strategy for improving advanced PCa treatment is targeted therapies combined with chemotherapy. PC-1, a prostate Leucine Zipper gene (PrLZ), is specifically expressed in prostate tissue as an androgen-induced gene and is up-regulated in advanced PCa. Recent work confirmed that PC-1 expr...
Autores principales: | Yu, Lan, Shang, Zeng-Fu, Wang, Jian, Wang, Hongtao, Huang, Fang, Zhang, Zhe, Wang, Ying, Zhou, Jianguang, Li, Shanhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653010/ https://www.ncbi.nlm.nih.gov/pubmed/26011939 |
Ejemplares similares
-
Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death
por: Shang, Zeng-Fu, et al.
Publicado: (2016) -
PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy
por: Zeng, Jin, et al.
Publicado: (2018) -
Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis
por: Chen, Wei, et al.
Publicado: (2017) -
ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression
por: Fan, Yizeng, et al.
Publicado: (2022) -
PC-1 works in conjunction with E3 ligase CHIP to regulate androgen receptor stability and activity
por: Wang, Jian, et al.
Publicado: (2016)